The aberrant FGFR4 pathway was identified in human cancers, which can be caused by gene amplification, post-transcriptional dysregulation, mutations, or alternative splicing of the FGFR4 gene, and the overexpression of its ligands in cancer or stromal cells [13,14,15,16]. Here, FGFR4 is linked to cancer.